HeartSciences Inc. (HSCSW)

Market Cap	3.86M
Revenue (ttm)	n/a
Net Income (ttm)	-8.52M
Shares Out	1.08M
EPS (ttm)	-10.22
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,094
Open	0.0900
Previous Close	n/a
Day's Range	0.0900 - 0.1400
52-Week Range	0.0300 - 0.2000
Beta	2.58
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 25, 2025

About HSCSW

HeartSciences Inc., a medical technology company, focuses on applying AI-based technology to an ECG to enhance its clinical utility. It is developing artificial intelligence-enhanced electrocardiography (AI-ECG) solutions, an algorithm to detect impaired cardiac relaxation or cardiac dysfunction caused by heart disease and/or age-related cardiac dysfunction; MyoVista wavECG device, a resting 12-lead ECG that provides diagnostic information related to cardiac dysfunction and conventional ECG information in the same test; and MyoVista Insights, a...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2007
• Employees: 15
• Stock Exchange: NASDAQ
• Ticker Symbol: HSCSW
• Website: https://heartsciences.com

Financial Performance

In 2024, HeartSciences's revenue was $18,600, an increase of 261.17% compared to the previous year's $5,150. Losses were -$6.61 million, 3.95% more than in 2023.